Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

2025133 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 405, Issue 10476, pp. 383-395

Field-Weighted Citation Impact: 135.01